`RESEARCH
`
`
`
`APPLICATION NUMBER:
`
`212640Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`
`
`MEMORANDUM
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`DATE:
`
`November 25, 2019
`
`TO:
`
`FROM:
`
`Administrative file for NDA 212640
`
`Michelle Mathers, Regulatory Health Project Manager/Neurology 1 Group
`Division of Regulatory Operations for Neuroscience/Office of Regulatory
`Operations/CDER
`
`SUBJECT: Officer/Employee List for NDA 212640
`
`APPLICATION/DRUG:
`
`NDA 212640/Exservan (riluzole) oral soluble film 50mg
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Basting, Eric
`Chelliah, Mariappan
`Chidambaram, Nallaperumal
`Choi, Young M.
`Dave, Kaushalkumar
`Heimann, Martha
`Gottipati, Gopichand
`Mada, Sripal
`Mathers, Michelle
`Paine, Rainer
`Rider, Briana
`Sabarinath, Sreedharan
`Shah, Sapna
`Tran, Suong
`Walters, Dahlia
`Williams, Sharon
`Wilson, Wendy
`Zhou, Tianhong Tim
`
`
`
`Reference ID: 4525245Reference ID: 4525554
`
`
`
`Signature Page 1 of 1
`--------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically. Following this are manifestations of any and all
`electronic signatures for this electronic record.
`--------------------------------------------------------------------------------------------
`/s/
`------------------------------------------------------------
`
`MICHELLE W MATHERS
`11/25/2019 03:51:26 PM
`
`
`
`Reference ID: 4525245Reference ID: 4525554
`
`